Carl D. Novina

Dana-Farber Cancer Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

39h-index9.9kcitations126works15.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(27), RNA Research and Splicing(23), RNA modifications and cancer(23), Cancer-related molecular mechanisms research(22), Cancer-related gene regulation(19)

Publications124 total

LncRNA SLNCR phenocopies the E2F1 DNA binding site to promote melanoma progression
Cell Reports·2025· 1 citedOpen Access
Abstract 2886: A <i>de novo</i> designed miniprotein enables modular and specific CAR-T targeting
Cancer Research·2025
De Novo Design of a Miniprotein That Functions As an Adapter for CAR-T Cells and Enables Modular Tumor Targeting for the Treatment of AML
Blood·2024Open Access
Author Correction: Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Nature Medicine·2024· 1 citedOpen Access
Abstract 3609: Chimeric cytokine receptors increase memory phenotypes and improve expansion and efficacy of CAR-T cell therapies
Cancer Research·2024
Correction for Song et al., “Sustained Small Interfering RNA-Mediated Human Immunodeficiency Virus Type 1 Inhibition in Primary Macrophages”
Journal of Virology·2023Open Access
P-194 Non-coding RNA LINC01410 interacts with the minichromosome maintenance (MCM) complex and is a dependency in multiple myeloma
Clinical Lymphoma Myeloma & Leukemia·2023
P-355 A novel genomewide RNA-Targeting CRISPR/ Cas13 screen identifies a plasma cell-specific long non-coding RNA (LncRNA) essential for myeloma cell growth
Clinical Lymphoma Myeloma & Leukemia·2023
Supplementary Table 3 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Figures and Legends from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Table 3 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Table 4 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Data from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Table 2 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Tables from Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E
2023Open Access
Supplementary Methods from Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E
2023Open Access
Supplementary Figures and Legends from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Table 1 from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary method from PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer
2023Open Access
Supplementary Methods from Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Cailin E. Joyce(8), Ananda L. Roy(8), Howell Moffett(7), Phillip A. Sharp(6), Maja M. Janas(6), Bingbing Wang(6), Derek M. Dykxhoorn(5), Venugopalan Cheriyath(5), Tara M. Love(4), Judy Lieberman(3), Akiko Shimamura(3), John G. Doench(3), Kai W. Wucherpfennig(3), Karyn Schmidt(3), William C. Hahn(2), Paul J. Beresford(2), Sang‐Kyung Lee(2), Premlata Shankar(2), Jennifer R. Brown(2), Özge Vargel Bölükbaşı(2)